This OCR reduction was accompanied by a significant decrease in the enzymatic activity of ETC complexes I and IV in CD4+ T cells and in whole PBMCs of untreated RRMS patients compared to healthy controls [80,81,91]. The gene discussed is CD4; the disease is relapsing-remitting multiple sclerosis.